T1	PROC 398 402	TACE
#1	AnnotatorNotes T1	C2711393; Transarterial chemoembolization of hepatic artery; Therapeutic or Preventive Procedure
T2	PROC 112 116	TACE
#2	AnnotatorNotes T2	C2711393; Transarterial chemoembolization of hepatic artery; Therapeutic or Preventive Procedure
T3	PROC 78 110	quimioembolización transarterial
#3	AnnotatorNotes T3	C3539919; Transarterial Chemoembolization; Therapeutic or Preventive Procedure
T4	CHEM 137 147	durvalumab
#4	AnnotatorNotes T4	C4055109; durvalumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	PROC 150 157	terapia
#5	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	DISO 191 214	carcinoma hepatocelular
#6	AnnotatorNotes T6	C2239176; Liver carcinoma; Neoplastic Process
T7	PROC 250 332	Ensayo fase III, multicéntrico, aleatorizado, doble ciego y controlado con placebo
T8	PROC 922 926	TACE
#7	AnnotatorNotes T8	C2711393; Transarterial chemoembolization of hepatic artery; Therapeutic or Preventive Procedure
T9	ANAT 1648 1664	gastrointestinal
#8	AnnotatorNotes T9	C0012240; Gastrointestinal system; Body System
T10	PROC 364 396	quimioembolización transarterial
#9	AnnotatorNotes T10	C3539919; Transarterial Chemoembolization; Therapeutic or Preventive Procedure
T11	CHEM 408 418	durvalumab
#10	AnnotatorNotes T11	C4055109; durvalumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T12	PROC 422 433	monoterapia
#11	AnnotatorNotes T12	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T13	CHEM 440 450	durvalumab
#12	AnnotatorNotes T13	C4055109; durvalumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	CHEM 455 466	bevacizumab
#13	AnnotatorNotes T14	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T15	DISO 484 507	carcinoma hepatocelular
#14	AnnotatorNotes T15	C2239176; Liver carcinoma; Neoplastic Process
T16	PROC 522 547	tratamiento locorregional
T17	DISO 584 600	cáncer de hígado
#15	AnnotatorNotes T17	C0345904; Malignant neoplasm of liver; Neoplastic Process
T18	DISO 617 636	cáncer en el hígado
T19	PROC 665 672	cirugía
#16	AnnotatorNotes T19	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T20	DISO 698 721	Carcinoma Hepatocelular
#17	AnnotatorNotes T20	C2239176; Liver carcinoma; Neoplastic Process
T21	DISO 783 807	enfermedad extrahepática
T22	DISO 811 821	Enfermedad
#18	AnnotatorNotes T22	C0012634; Disease; Disease or Syndrome
T23	PROC 840 847	cirugía
#19	AnnotatorNotes T23	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T24	PROC 859 869	trasplante
#20	AnnotatorNotes T24	C0040732; Transplantation; Therapeutic or Preventive Procedure
T25	PROC 872 880	ablación
#21	AnnotatorNotes T25	C0547070; Ablation; Therapeutic or Preventive Procedure
T26	DISO 896 906	enfermedad
#22	AnnotatorNotes T26	C0012634; Disease; Disease or Syndrome
T27	DISO 1073 1091	Enfermedad medible
#23	AnnotatorNotes T27	C1513041; Measurable Disease; Disease or Syndrome
T28	ANAT 1137 1143	órgano
#24	AnnotatorNotes T28	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T29	ANAT 1146 1152	médula
#25	AnnotatorNotes T29	C0005953; Bone Marrow; Tissue | C0376152; Marrow; Body Part, Organ, or Organ Component
T30	DISO 1206 1236	síndrome nefrótico o nefrítico
T31	ANAT 1703 1719	gastrointestinal
#26	AnnotatorNotes T31	C0012240; Gastrointestinal system; Body System
T32	DISO 1240 1265	Enfermedad cardiovascular
#27	AnnotatorNotes T32	C0007222; Cardiovascular Diseases; Disease or Syndrome
T33	ANAT 1836 1839	Vp3
T34	DISO 1347 1372	accidente cerebrovascular
#28	AnnotatorNotes T34	C0038454; Cerebrovascular accident; Disease or Syndrome
T35	DISO 1378 1398	infarto de miocardio
#29	AnnotatorNotes T35	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T36	DISO 1440 1452	coagulopatía
#30	AnnotatorNotes T36	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T37	DISO 1455 1475	diátesis hemorrágica
#31	AnnotatorNotes T37	C1458140; Bleeding tendency; Pathologic Function
T38	PROC 1519 1526	cirugía
#32	AnnotatorNotes T38	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T39	PROC 1555 1563	biopsias
#33	AnnotatorNotes T39	C0005558; Biopsy; Diagnostic Procedure
T40	DISO 1616 1633	fístula abdominal
T41	DISO 1636 1664	perforación gastrointestinal
T42	DISO 1666 1681	úlcera gástrica
#34	AnnotatorNotes T42	C0038358; Gastric ulcer; Disease or Syndrome
T43	DISO 1694 1719	sangrado gastrointestinal
#35	AnnotatorNotes T43	C0017181; Gastrointestinal Hemorrhage; Pathologic Function
T44	ANAT 1842 1845	Vp4
T45	DISO 1809 1835	trombosis de la vena porta
#36	AnnotatorNotes T45	C0155773; Portal Vein Thrombosis; Disease or Syndrome
T46	CHEM 162 173	bevacizumab
#37	AnnotatorNotes T46	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T47	ANAT 201 214	hepatocelular
#38	AnnotatorNotes T47	C0227525; Hepatocyte; Cell
T48	ANAT 494 507	hepatocelular
#39	AnnotatorNotes T48	C0227525; Hepatocyte; Cell
T49	ANAT 594 600	hígado
#40	AnnotatorNotes T49	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T50	ANAT 630 636	hígado
#41	AnnotatorNotes T50	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T51	ANAT 708 721	Hepatocelular
#42	AnnotatorNotes T51	C0227525; Hepatocyte; Cell
T52	ANAT 1251 1265	cardiovascular
#43	AnnotatorNotes T52	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T53	DISO 1311 1333	evento arterioembólico
T54	ANAT 1389 1398	miocardio
#44	AnnotatorNotes T54	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T55	ANAT 1624 1633	abdominal
#45	AnnotatorNotes T55	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T56	ANAT 1673 1681	gástrica
#46	AnnotatorNotes T56	C0038351; Stomach; Body Part, Organ, or Organ Component | C1278920; Entire stomach; Body Part, Organ, or Organ Component | C3714551; Stomach structure; Body Part, Organ, or Organ Component
T57	ANAT 1825 1835	vena porta
#47	AnnotatorNotes T57	C0032718; Portal vein structure; Body Part, Organ, or Organ Component | C1305775; Entire portal vein; Body Part, Organ, or Organ Component
T58	Date 13 17	2018
T59	LIVB 177 186	pacientes
#48	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 470 479	pacientes
#49	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	LIVB 570 579	Pacientes
#50	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Neg_cue 647 649	no
T63	Neg_cue 763 765	No
T64	Neg_cue 822 824	no
T65	Spec_cue 907 921	susceptible de
T66	PROC 943 953	Child-Pugh
#51	AnnotatorNotes T66	C3854424; Child-Pugh-Turcotte score; Laboratory Procedure
T67	Date 1430 1436	actual
T68	LIVB 1478 1487	pacientes
#52	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Duration 1530 1549	los últimos 28 días
T70	Neg_cue 1570 1577	exentas
T72	Duration 1737 1748	los 6 meses
T73	Neg_cue 1779 1790	Se excluyen
T74	LIVB 1795 1804	pacientes
#53	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T76	PHYS 1117 1124;1134 1143	Función de órgano
#54	AnnotatorNotes T76	C1254358; Organ or Tissue Function; Organ or Tissue Function
T71	PHYS 1117 1124;1134 1136;1146 1152	Función de médula
#55	AnnotatorNotes T71	C1254358; Organ or Tissue Function; Organ or Tissue Function
T75	PROC 969 985	estado funcional
#56	AnnotatorNotes T75	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T77	PROC 1763 1776	reclutamiento
#57	AnnotatorNotes T77	C0242800; Patient Recruitment; Research Activity
A1	Assertion T19 Negated
A2	Assertion T21 Negated
A3	Assertion T23 Negated
A4	Assertion T24 Negated
A5	Assertion T25 Negated
A6	Assertion T8 Speculated
A7	Assertion T39 Negated
A8	Assertion T74 Negated
A9	Assertion T45 Negated
A10	Status T30 History_of
A11	Status T53 History_of
A12	Status T34 History_of
A13	Status T35 History_of
A14	Status T36 History_of
A15	Status T37 History_of
A16	Status T38 History_of
A17	Status T40 History_of
A18	Status T41 History_of
A19	Status T42 History_of
A20	Status T43 History_of
#58	AnnotatorNotes T7	C0282461; Phase 3 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#59	AnnotatorNotes T18	C0345904; Malignant neoplasm of liver; Neoplastic Process
#60	AnnotatorNotes T67	C0521116; Current (present time); Temporal Concept 
#61	AnnotatorNotes T30	C0027726; Nephrotic Syndrome; Disease or Syndrome + C0268732; Nephritic syndrome; Disease or Syndrome 
#62	AnnotatorNotes T40	C1879311; abdominal fistula; Anatomical Abnormality 
#63	AnnotatorNotes T41	C0151664; Gastrointestinal perforation; Disease or Syndrome 
T78	Neg_cue 1682 1684	no
T79	Observation 1685 1691	curada
A21	Assertion T79 Negated
#64	AnnotatorNotes T79	C0184780; Disease condition determination, cured; Finding
R1	Negation Arg1:T63 Arg2:T21	
R2	Negation Arg1:T64 Arg2:T23	
T80	Quantifier_or_Qualifier 848 856	curativa
A22	Assertion T80 Negated
R3	Negation Arg1:T64 Arg2:T80	
R4	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T80	
R5	Negation Arg1:T64 Arg2:T24	
R6	Negation Arg1:T64 Arg2:T25	
T81	Quantifier_or_Qualifier 881 889	curativa
A23	Assertion T81 Negated
R7	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T81	
R8	Negation Arg1:T64 Arg2:T81	
R9	Speculation Arg1:T65 Arg2:T8	
R10	Negation Arg1:T70 Arg2:T39	
R11	Negation Arg1:T78 Arg2:T79	
R12	Negation Arg1:T73 Arg2:T74	
R13	Experiences Arg1:T74 Arg2:T45	
R14	Negation Arg1:T73 Arg2:T45	
R15	Location_of Arg1:T57 Arg2:T45	
R16	Location_of Arg1:T33 Arg2:T45	
R17	Location_of Arg1:T44 Arg2:T45	
R18	Negation Arg1:T62 Arg2:T19	
R19	Combined_with Arg1:T3 Arg2:T4	
R20	Combined_with Arg1:T2 Arg2:T4	
R21	Experiences Arg1:T59 Arg2:T3	
R22	Experiences Arg1:T59 Arg2:T2	
R23	Location_of Arg1:T47 Arg2:T6	
T82	Quantifier_or_Qualifier 215 228	locorregional
R24	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T82	
R25	Experiences Arg1:T59 Arg2:T6	
R26	Used_for Arg1:T46 Arg2:T5	
R27	Combined_with Arg1:T10 Arg2:T11	
R28	Combined_with Arg1:T1 Arg2:T11	
R29	Used_for Arg1:T11 Arg2:T12	
R30	Combined_with Arg1:T10 Arg2:T13	
R31	Combined_with Arg1:T1 Arg2:T13	
R32	Combined_with Arg1:T13 Arg2:T14	
R33	Combined_with Arg1:T4 Arg2:T5	
R34	Experiences Arg1:T60 Arg2:T10	
R35	Experiences Arg1:T60 Arg2:T1	
R36	Experiences Arg1:T60 Arg2:T15	
R37	Location_of Arg1:T48 Arg2:T15	
R38	Experiences Arg1:T60 Arg2:T16	
R39	Experiences Arg1:T61 Arg2:T17	
R40	Location_of Arg1:T49 Arg2:T17	
R41	Location_of Arg1:T51 Arg2:T20	
T83	Quantifier_or_Qualifier 722 735	Locorregional
R42	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T83	
R43	Experiences Arg1:T61 Arg2:T18	
R44	Location_of Arg1:T50 Arg2:T18	
T84	Quantifier_or_Qualifier 605 609	solo
R45	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T84	
R46	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T84	
R47	Experiences Arg1:T61 Arg2:T19	
#65	AnnotatorNotes T80	C1880198; Cure (remedy); Conceptual Entity (?)
#66	AnnotatorNotes T81	C1880198; Cure (remedy); Conceptual Entity (?)
T85	Result_or_Value 954 966	clase A a B7
R48	Has_Result_or_Value Arg1:T66 Arg2:T85	
T86	CONC 989 1023	Eastern Cooperative Oncology Group
#67	AnnotatorNotes T86	C1520224; ECOG performance status; Intellectual Product
T87	Result_or_Value 1034 1039	0 o 1
R49	Has_Result_or_Value Arg1:T86 Arg2:T87	
R50	Used_for Arg1:T86 Arg2:T75	
T88	CONC 1060 1069	inclusión
#68	AnnotatorNotes T88	C1512693; Inclusion; Qualitative Concept
R51	Overlap Arg1:T75 Arg2:T88	
R52	Overlap Arg1:T66 Arg2:T88	
T89	CONC 1096 1113	criterios mRECIST
#69	AnnotatorNotes T89	C4288721; Modified RECIST Lencioni Liver Cancer 2010 Oncology Response Criteria; Intellectual Produc
R53	Location_of Arg1:T28 Arg2:T76	
R54	Location_of Arg1:T29 Arg2:T71	
T90	Observation 1117 1152	Función adecuada de órgano y médula
R55	Location_of Arg1:T52 Arg2:T32	
T91	Quantifier_or_Qualifier 1266 1292	clínicamente significativa
R56	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T91	
R57	Location_of Arg1:T54 Arg2:T35	
R58	Overlap Arg1:T36 Arg2:T67	
R59	Overlap Arg1:T37 Arg2:T67	
R60	Experiences Arg1:T68 Arg2:T36	
R61	Experiences Arg1:T68 Arg2:T37	
R62	Experiences Arg1:T68 Arg2:T38	
R63	Overlap Arg1:T38 Arg2:T69	
R64	Experiences Arg1:T68 Arg2:T39	
#70	AnnotatorNotes T53	C4554659; Arterial Thromboembolism, CTCAE; Finding 
R65	Location_of Arg1:T55 Arg2:T40	
R66	Location_of Arg1:T9 Arg2:T41	
R67	Location_of Arg1:T56 Arg2:T42	
R68	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T79	
R69	Location_of Arg1:T31 Arg2:T43	
R70	Overlap Arg1:T43 Arg2:T72	
R71	Before Arg1:T43 Arg2:T77	
T92	Quantifier_or_Qualifier 1720 1726	activo
#71	AnnotatorNotes T92	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R72	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T92	
T93	CONC 1025 1029	ECOG
#72	AnnotatorNotes T93	C1520224; ECOG performance status; Intellectual Product
R73	Has_Result_or_Value Arg1:T93 Arg2:T87	
R74	Used_for Arg1:T93 Arg2:T75	
#73	AnnotatorNotes T91	C5209294; Clinical relevance; Intellectual Product
#74	AnnotatorNotes T82	C0205276; Local; Spatial Concept (?)
#75	AnnotatorNotes T84	C0205171; Singular; Quantitative Concept (?)
#76	AnnotatorNotes T83	C0205276; Local; Spatial Concept (?)
#77	AnnotatorNotes T16	C1517925; Local Therapy; Therapeutic or Preventive Procedure (?)
A24	Experiencer T59 Patient
A25	Experiencer T60 Patient
A26	Experiencer T61 Patient
A27	Experiencer T68 Patient
A28	Experiencer T74 Patient
